肺鳞癌-话题@MedSci

#肺鳞癌#

34篇内容 | 2723人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2258431, encodeId=6be822584315f, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a> <a href='/topic/show?id=356b112349dd' target=_blank style='color:#2F92EE;'>#欧洲肺癌大会#</a>, objectTitle=超1/4患者生存突破5年，5年病情无进展患者比例翻6倍之多！周彩存教授：卡瑞利珠单抗联合化疗或重塑肺癌患者治疗选择, objectType=article, longId=869433, objectId=66918694330e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-doctor-hand-with-pen-BWV9L2K.jpg, objectUrl=/article/show_article.do?id=66918694330e, replyNumber=0, likeNumber=10, createdTime=2025-03-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66918694330e, moduleTitle=超1/4患者生存突破5年，5年病情无进展患者比例翻6倍之多！周彩存教授：卡瑞利珠单抗联合化疗或重塑肺癌患者治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66918694330e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2249757, encodeId=e8b32249e5787, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a> <a href='/topic/show?id=5c2499943b0' target=_blank style='color:#2F92EE;'>#靶向药#</a>, objectTitle=肺鳞癌基因突变有无靶向药？从不吸烟患者的基因突变可能性10倍于吸烟肺癌患者！, objectType=article, longId=860946, objectId=8dab86094697, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240715/1721034882230_5579292.jpg, objectUrl=/article/show_article.do?id=8dab86094697, replyNumber=0, likeNumber=8, createdTime=2025-01-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=8dab86094697, moduleTitle=肺鳞癌基因突变有无靶向药？从不吸烟患者的基因突变可能性10倍于吸烟肺癌患者！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dab86094697)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239486, encodeId=c0ff22394861a, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a> <a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=神奇的逆转，单药PD-1让无药可用PD-L1低表达肺鳞癌病情稳定26个月了！, objectType=article, longId=852432, objectId=8b5785243295, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732686226246_8538692.jpg, objectUrl=/article/show_article.do?id=8b5785243295, replyNumber=0, likeNumber=30, createdTime=2024-11-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=8b5785243295, moduleTitle=神奇的逆转，单药PD-1让无药可用PD-L1低表达肺鳞癌病情稳定26个月了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b5785243295)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194525, encodeId=21812194525c6, content=<a href='/topic/show?id=4bbf8228ef5' target=_blank style='color:#2F92EE;'>#肺结节#</a> <a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a> <a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a> <a href='/topic/show?id=c0db1125344f' target=_blank style='color:#2F92EE;'>#低分化癌#</a>, objectTitle=误诊反思：这个问诊时我讲得头头是道的病例，结果证实误判了！回头再分析有何经验能借鉴？, objectType=article, longId=817331, objectId=ae1181e33199, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=ae1181e33199, replyNumber=0, likeNumber=142, createdTime=2024-03-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ae1181e33199, moduleTitle=误诊反思：这个问诊时我讲得头头是道的病例，结果证实误判了！回头再分析有何经验能借鉴？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae1181e33199)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177968, encodeId=56e821e7968f0, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a> <a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a> <a href='/topic/show?id=435599e72f3' target=_blank style='color:#2F92EE;'>#非鳞状NSCLC#</a>, objectTitle=肺鳞癌vs非鳞癌，哪些PD-L1表达的患者用免疫治疗效果更好?, objectType=article, longId=807269, objectId=52e980e269fc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=52e980e269fc, replyNumber=0, likeNumber=141, createdTime=2023-12-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=52e980e269fc, moduleTitle=肺鳞癌vs非鳞癌，哪些PD-L1表达的患者用免疫治疗效果更好?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52e980e269fc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2170195, encodeId=0ce721e019578, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小细胞肺癌#</a> <a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=重复活检有必要！肺鳞癌免疫治疗耐药，竟变为小细胞肺癌, objectType=article, longId=801710, objectId=ac62801e10ab, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867316202_4754896.png, objectUrl=/article/show_article.do?id=ac62801e10ab, replyNumber=0, likeNumber=156, createdTime=2023-11-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ac62801e10ab, moduleTitle=重复活检有必要！肺鳞癌免疫治疗耐药，竟变为小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac62801e10ab)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1391493, encodeId=9cf61391493ba, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Cancers ：糖尿病严重程度和病死率与肺鳞癌的关系, objectType=article, longId=728778, objectId=9c48e28778e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c48e28778e7, replyNumber=0, likeNumber=98, createdTime=2022-06-08, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c48e28778e7, moduleTitle=Cancers ：糖尿病严重程度和病死率与肺鳞癌的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c48e28778e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391492, encodeId=9d9c1391492ae, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=王兆宇教授：肺鳞癌的病理影像学, objectType=article, longId=724321, objectId=1a38e24321d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a38e24321d3, replyNumber=0, likeNumber=77, createdTime=2022-04-16, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a38e24321d3, moduleTitle=王兆宇教授：肺鳞癌的病理影像学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a38e24321d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391491, encodeId=082f139149148, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=肺鳞癌化疗进展,选择安罗替尼+PD-1如何?, objectType=article, longId=295640, objectId=05132956406b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05132956406b, replyNumber=0, likeNumber=118, createdTime=2022-02-16, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05132956406b, moduleTitle=肺鳞癌化疗进展,选择安罗替尼+PD-1如何?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05132956406b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391490, encodeId=665a13914905c, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=J Cancer Res Clin Oncol：广医一院团队真实世界数据发现Sintilimab（信迪利单抗）联合紫杉醇+铂类或可进一步改善晚期肺鳞癌的生存, objectType=article, longId=292997, objectId=720229299ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=720229299ed0, replyNumber=0, likeNumber=136, createdTime=2021-12-30, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=720229299ed0, moduleTitle=J Cancer Res Clin Oncol：广医一院团队真实世界数据发现Sintilimab（信迪利单抗）联合紫杉醇+铂类或可进一步改善晚期肺鳞癌的生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=720229299ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391489, encodeId=1ea0139148921, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享, objectType=article, longId=221017, objectId=e99622101e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99622101e22, replyNumber=0, likeNumber=95, createdTime=2021-11-27, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99622101e22, moduleTitle=肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e99622101e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391488, encodeId=86f913914884c, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=替吉奥联合同步放疗晚期肺鳞癌及影响因素分析, objectType=article, longId=220707, objectId=25d8220e0776, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d8220e0776, replyNumber=0, likeNumber=186, createdTime=2021-11-22, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d8220e0776, moduleTitle=替吉奥联合同步放疗晚期肺鳞癌及影响因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d8220e0776)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391487, encodeId=f6a5139148ea7, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=J Clin Oncol：Veliparib联合卡铂+紫杉醇化疗作为晚期肺鳞癌的一线治疗的效果, objectType=article, longId=216406, objectId=13bc21640686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13bc21640686, replyNumber=0, likeNumber=100, createdTime=2021-08-29, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13bc21640686, moduleTitle=J Clin Oncol：Veliparib联合卡铂+紫杉醇化疗作为晚期肺鳞癌的一线治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13bc21640686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391486, encodeId=3787139148601, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=Ⅳ期肺鳞癌病人治疗方案, objectType=article, longId=215303, objectId=3d5e2153031b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d5e2153031b, replyNumber=0, likeNumber=0, createdTime=2021-08-06, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d5e2153031b, moduleTitle=Ⅳ期肺鳞癌病人治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d5e2153031b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391485, encodeId=feeb1391485cd, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, objectType=article, longId=195059, objectId=f74a195059c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f74a195059c2, replyNumber=0, likeNumber=98, createdTime=2020-06-02, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f74a195059c2, moduleTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f74a195059c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391484, encodeId=9abd139148435, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, objectType=article, longId=184137, objectId=74cc18413e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74cc18413e05, replyNumber=0, likeNumber=177, createdTime=2019-12-05, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74cc18413e05, moduleTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74cc18413e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391483, encodeId=c1cf139148324, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=病例:一例纵隔型肺鳞癌的二线免疫治疗, objectType=article, longId=183917, objectId=681618391ec1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=681618391ec1, replyNumber=0, likeNumber=81, createdTime=2019-12-03, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=681618391ec1, moduleTitle=病例:一例纵隔型肺鳞癌的二线免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=681618391ec1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391482, encodeId=75a4139148269, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大, objectType=article, longId=183912, objectId=fc8b1839120b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc8b1839120b, replyNumber=0, likeNumber=114, createdTime=2019-12-03, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc8b1839120b, moduleTitle=中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc8b1839120b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391481, encodeId=dad0139148182, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=信迪利单抗联合化疗用于晚期肺鳞癌二线治疗，肿瘤持续缓解7个月以上, objectType=article, longId=181304, objectId=4eaa18130437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eaa18130437, replyNumber=0, likeNumber=116, createdTime=2019-10-17, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eaa18130437, moduleTitle=信迪利单抗联合化疗用于晚期肺鳞癌二线治疗，肿瘤持续缓解7个月以上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eaa18130437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1391480, encodeId=bc221391480e4, content=<a href='/topic/show?id=e944823960d' target=_blank style='color:#2F92EE;'>#肺鳞癌#</a>, objectTitle=肺癌丨精准医疗，肺鳞癌的诊疗, objectType=article, longId=176940, objectId=80161e694002, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80161e694002, replyNumber=0, likeNumber=146, createdTime=2019-08-06, rootId=0, userName=ms9476844295372110, userId=91c62500083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80161e694002, moduleTitle=肺癌丨精准医疗，肺鳞癌的诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80161e694002)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺鳞癌

2020-05-29

梅斯管理员

#肺鳞癌# #欧洲肺癌大会#

超1/4患者生存突破5年，5年病情无进展患者比例翻6倍之多！周彩存教授：卡瑞利珠单抗联合化疗或重塑肺癌患者治疗选择

2025-03-30

梅斯管理员

#肺鳞癌# #靶向药#

肺鳞癌基因突变有无靶向药？从不吸烟患者的基因突变可能性10倍于吸烟肺癌患者！

2025-01-27发表于陕西省

梅斯管理员

#肺鳞癌# #PD-L1#

神奇的逆转，单药PD-1让无药可用PD-L1低表达肺鳞癌病情稳定26个月了！

2024-11-27发表于陕西省

梅斯管理员

#肺结节# #肺鳞癌# #鳞癌# #低分化癌#

误诊反思：这个问诊时我讲得头头是道的病例，结果证实误判了！回头再分析有何经验能借鉴？

2024-03-21发表于上海

梅斯管理员

#肺癌# #免疫治疗# #肺鳞癌# #PD-L1# #非鳞状NSCLC#

肺鳞癌vs非鳞癌，哪些PD-L1表达的患者用免疫治疗效果更好?

2023-12-29发表于上海

梅斯管理员

#小细胞肺癌# #免疫治疗# #肺鳞癌#

重复活检有必要！肺鳞癌免疫治疗耐药，竟变为小细胞肺癌

2023-11-22发表于上海

ms9476844295372110

#肺鳞癌#

Cancers ：糖尿病严重程度和病死率与肺鳞癌的关系

2022-06-08

ms9476844295372110

#肺鳞癌#

王兆宇教授：肺鳞癌的病理影像学

2022-04-16

ms9476844295372110

#肺鳞癌#

肺鳞癌化疗进展,选择安罗替尼+PD-1如何?

2022-02-16

ms9476844295372110

#肺鳞癌#

J Cancer Res Clin Oncol：广医一院团队真实世界数据发现Sintilimab（信迪利单抗）联合紫杉醇+铂类或可进一步改善晚期肺鳞癌的生存

2021-12-30

ms9476844295372110

#肺鳞癌#

肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享

2021-11-27

ms9476844295372110

#肺鳞癌#

替吉奥联合同步放疗晚期肺鳞癌及影响因素分析

2021-11-22

ms9476844295372110

#肺鳞癌#

J Clin Oncol：Veliparib联合卡铂+紫杉醇化疗作为晚期肺鳞癌的一线治疗的效果

2021-08-29

ms9476844295372110

#肺鳞癌#

Ⅳ期肺鳞癌病人治疗方案

2021-08-06

ms9476844295372110

#肺鳞癌#

ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值

2020-06-02

ms9476844295372110

#肺鳞癌#

PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR

2019-12-05

ms9476844295372110

#肺鳞癌#

病例:一例纵隔型肺鳞癌的二线免疫治疗

2019-12-03

ms9476844295372110

#肺鳞癌#

中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大

2019-12-03

ms9476844295372110

#肺鳞癌#

信迪利单抗联合化疗用于晚期肺鳞癌二线治疗，肿瘤持续缓解7个月以上

2019-10-17

ms9476844295372110

#肺鳞癌#

肺癌丨精准医疗，肺鳞癌的诊疗

2019-08-06